 |
|
|
|
|
| COMPANY |
SYMBOL |
$MM |
INDUSTRY |
TRANSACTION |
| Affymax, Inc. |
AFFY |
$60.0 * |
Biopharmaceutical |
Managed Equity Facility |
| AirLink Communications, Inc. |
Private |
$6.5 |
Technology |
Venture Debt Facility |
| Alexza Pharmaceuticals, Inc. |
ALXA |
$25.0 * |
Biopharmaceutical |
Committed Equity Facility (2010) |
| Alexza Pharmaceuticals, Inc. |
ALXA |
$50.0 * |
Biopharmaceutical |
Committed Equity Facility (2008) |
| Arena Pharmaceuticals, Inc. |
ARNA |
$35.0 |
Biotech |
Equity |
| ARIAD Pharmaceuticals |
ARIA |
$50.0 * |
Biotech |
Committed Equity Facility (2007) |
| ARIAD Pharmaceuticals |
ARIA |
$75.0 * |
Biotech |
Committed Equity Facility (2000) |
ARIUS Research, Inc.
(acquired by Roche 9/08) |
TSX: ARI |
$192 |
Biotech |
Co-Advisor to ARIUS; Acquisition by Roche |
| AVANIR Pharmaceuticals |
AVNR |
$54.0 ‡ |
Biotech |
Sale of FazaClo® to Azur Pharma |
| Aviron (acquired by Medimmune 1/02) |
AVIR |
$84.0 |
Healthcare |
Committed Equity Facility |
| BioMarin Pharmaceuticals Inc. |
BMRN |
$27.7 * |
Healthcare |
Committed Equity Facility |
| Celsion Corporation |
CLSN |
$15.0 * |
Healthcare |
Committed Equity Facility |
| Cleveland Biolabs, Inc. |
CBLI |
$5.5 |
Biopharmaceutical |
Equity |
| Columbia Laboratories, Inc. |
CBRX |
$20.0 |
Healthcare |
Committed Equity Facility |
CV Therapeutics
(acquired by Gilead Sciences, Inc. 4/09) |
CVTX |
$200 *
$25.0
$237.0 |
Biotech |
Committed Equity Facility
Equity
Committed Equity Facility |
| Dendreon Corporation |
DNDN |
$130.0 * |
Biotech |
Committed Equity Facility |
| Depomed, Inc. |
DEPO |
$30.0 * |
Pharmaceutical |
Committed Equity Facility |
Digene Corporation
(acquired by Qiagen NV 7/07) |
DIGE |
$15.0 |
Healthcare |
Equity |
| DURECT Corporation |
DRRX |
$50.0 * |
Pharmaceutical |
Committed Equity Facility |
| Dyax Corporation |
DYAX |
$50.0 * |
Biotech |
Committed Equity Facility |
| EMCORE Corporation |
EMKR |
$25.0 * |
Technology |
Committed Equity Facility |
Encysive Pharmaceuticals Inc.
(acquired by Pfizer 4/08) |
ENCY |
$75.0 * |
Pharmaceutical |
Committed Equity Facility |
Epoch Biosciences, Inc.
(acquired by Nanogen 12/04) |
EBIO |
$6.2 |
Biotech |
Equity |
| eSuites Hotels, LLC |
Private |
$100.0
$27.0 |
Hotels/Lodging |
Senior Mortgage
Mezzanine Financing |
| Fleetwood Enterprises, Inc. |
FLE |
$20.0 |
RVs/Mobile Homes |
Equity |
| Geron Corporation |
GERN |
$50.0 |
Biotech |
Committed Equity Facility |
IGEN International, Inc.
(acquired by Roche 2/04) |
IGEN |
$126.8 |
Technology |
Equity |
| Isis Pharmaceuticals, Inc. |
ISIS |
$75.0 * |
Pharmaceutical |
Committed Equity Facility |
| Jones Soda Co. |
JSDA |
$10.0 * |
Soft Drinks |
Committed Equity Facility |
| Lexicon Pharmaceuticals, Inc. |
LXRX |
$75.0 * |
Biotech |
Committed Equity Facility |
Loud Technologies, Inc.
(f/k/a Mackie Designs Inc.) |
LTEC |
$54.0 |
Audio Equipment |
Equity & Revolving Credit Facility/Term Loan(s) |
| MAP Pharmaceuticals, Inc. |
MAPP |
$60.0 * |
Biopharmaceutical |
Committed Equity Facility |
| Medivation, Inc. |
MDVN |
$100.0 * |
Biotech |
Committed Equity Facility |
| Metropolitan Health Networks Inc. |
MDF |
$2.5 |
Healthcare |
Equity |
| Microvision, Inc. |
MVIS |
$60.0 * |
Technology |
Committed Equity Facility |
| Myriad Genetics |
MYGN |
$63.0 |
Biotech |
Equity |
| Nektar Therapeutics |
NKTR |
$32.0 |
Healthcare |
Equity |
| NPS Pharmaceuticals, Inc. |
NPSP |
$40.0 * |
Biopharmaceutical |
Committed Equity Facility |
| Omeros Corporation |
OMER |
$40.0 * |
Biopharmaceutical |
Committed Equity Facility |
| Oncothyreon Inc. |
ONTY |
$20.0 * |
Biotech |
Committed Equity Facility |
| Onyx Pharmaceuticals, Inc. |
ONXX |
$150.0 * |
Pharmaceutical |
Committed Equity Facility |
PacifiCare Health Systems Inc.
(acquired by UnitedHealth Group 12/05) |
PHS |
$150.0 * |
Healthcare |
Committed Equity Facility |
| Palm, Inc. |
PALM |
$18.0 |
Technology |
Equity |
Poniard Pharmaceuticals, Inc.
(f/k/a NeoRx Corporation) |
PARD |
$14.7
$60.0 * |
Biopharmaceutical |
Equity
Committed Equity Facility |
| Reliant Pharmaceuticals, LLC |
Private |
$15.0 |
Pharmaceutical |
Equity (Series D) |
SangStat Medical Corp.
(acquired by Genzyme Corp. 8/03) |
SANG |
$30.0 |
Pharmaceutical |
Revolving Line of Credit |
| Solexa, Inc. (acquired by Ilumina 11/06) |
SLXA |
$75.0 * |
Biotech |
Committed Equity Facility |
| Star Scientific, Inc. |
STSI |
$13.0 |
Tobacco |
Equity |
| Sun Communities, Inc. |
SUI |
$100.0 * |
REIT |
Committed Equity Facility |
| Syntroleum |
SYNM |
$10.0 * |
Energy |
Committed Equity Facility |
| Threshold Pharmaceuticals, Inc. |
THLD |
$35.0 |
Biotech |
Equity |
| TiVo Inc. |
TIVO |
$14.0 |
Technology, Broadcasting |
Committed Equity Facility |
| Triax Holdings, LLC |
Private |
$77.0
$56.0 |
Pharmaceutical |
Equity
Senior Debt Facility |
| Trinity Industries, Inc. |
TRN |
$31.5 |
Transportation |
Equity |
| Tutogen Medical, Inc. (acquired by RTI Biologics 2/08) |
TTG |
$3.0 |
Healthcare |
Equity |
| Vical Incorporated |
VICL |
$25.0 * |
Biopharmaceutical |
Committed Equity Facility |
| Yahoo (private placement of insider stock owned by Softbank) |
YHOO |
$191.0 |
Technology |
Equity |
| XOMA, Ltd. |
XOMA |
$60.0 * |
Biopharmaceutical |
Committed Equity Facility |
|
|
|
|
|
*Amount reflects overall purchase commitment(s) facilitated by Reedland and not necessarily the total amount of securities that will be sold pursuant to applicable purchase agreements.
** Facilitated via McMahan Securities.
‡ Amount inclusive of up to an additional $12MM in 2009 contingent payments and product royalties. |
